• 4D Molecular Therapeutics, Inc. (NASDAQ:FDMT) Receives Average Rating of "Buy" from Analysts

    Источник: Buzz FX / 23 сен 2024 04:01:10   America/Chicago


    4D Molecular Therapeutics, Inc. (NASDAQ:FDMT) Receives Average Rating of "Buy" from Analysts Written by MarketBeat September 23, 2024 Share Link copied to clipboard. Shares of 4D Molecular Therapeutics, Inc.
    Read more...
Опубликовать